Belantamab mafodotin associated corneal microcyst-like epithelial changes
Purpose: To report a case of bilateral corneal microcyst-like epithelial changes associated with belantamab mafodotin (belamaf) therapy. Observations: A 70-year-old man with refractory multiple myeloma was placed on belamaf, a recently FDA-approved treatment for relapsed or refractory multiple myelo...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Inc.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |